Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIREFISH: Risdiplam in Infants with Type 1 SMA
NCT02913482Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2016
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 2 trial of risdiplam in spinal muscular atrophy type 1, sponsored by Roche. Started Dec 2016; status: completed.
02
Drugs
risdiplam
03
Conditions
spinal muscular atrophy type 1
Beyond the preview
Go deeper on NCT02913482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02913482.